BackEton Pharmaceuticals Overview

Eton Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ETON.

Quarterly EBIT

$2.41M
613.62% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$2.04M
189.99% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)